|
RC3H1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62503344114384E-12 |
| Normal-vs-Stage2 |
1.73272507453248E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
7.098800E-01 |
| Stage1-vs-Stage3 |
7.702200E-02 |
| Stage1-vs-Stage4 |
7.011700E-04 |
| Stage2-vs-Stage3 |
1.120830E-01 |
| Stage2-vs-Stage4 |
4.579800E-03 |
| Stage3-vs-Stage4 |
1.138630E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
5.66520053091324E-10 |
| Normal-vs-Asian |
7.105427357601E-15 |
| Caucasian-vs-AfricanAmerican |
9.559400E-01 |
| Caucasian-vs-Asian |
7.665400E-01 |
| AfricanAmerican-vs-Asian |
8.051000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
7.013000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.363050E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.433400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.893450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.603800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.973000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.398200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.119400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.48199999997034E-06 |
| Classical-VS-Follicular |
7.367000E-01 |
| Classical-VS-Other |
5.966000E-01 |
| Classical-VS-Normal |
1.63224989080391E-12 |
| Tall-VS-Follicular |
1.991000E-04 |
| Tall-VS-Other |
2.623600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.000200E-01 |
| Follicular-VS-Normal |
1.63324909152607E-12 |
| Other-VS-Normal |
9.58399999999582E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
7.622100E-02 |
|
|
